Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia
Clinical trial NCT02677324 · COMPLETED
Trial details
- NCT number
- NCT02677324
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-09
- Primary completion
- 2020-02-14
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.